Clinical Trial Update: Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating a regimen of a monoclonal antibody therapy with paclitaxel and cyclosporine in patients with recurrent or refractory No…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Monoclonal antibody therapy
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of California, Davis | Conditions: Lymphoma | Phase 1 | Status: UNKNOWN